These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 27076287)

  • 1. Challenges in Veterinary Vaccine Development and Immunization.
    Chambers MA; Graham SP; La Ragione RM
    Methods Mol Biol; 2016; 1404():3-35. PubMed ID: 27076287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modern veterinary vaccines and the Shaman's apprentice.
    Carter PB; Carmichael LE
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):389-400. PubMed ID: 12818624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens.
    Dey AK; Srivastava IK
    Expert Rev Vaccines; 2011 Feb; 10(2):227-51. PubMed ID: 21105782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvants in veterinary vaccines: modes of action and adverse effects.
    Spickler AR; Roth JA
    J Vet Intern Med; 2003; 17(3):273-81. PubMed ID: 12774966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: Advanced Immunization Technologies for Next Generation Vaccines.
    Medaglini D; Andersen P; Rappuoli R
    Front Immunol; 2020; 11():878. PubMed ID: 32435250
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccine adjuvants.
    Macy DW
    Semin Vet Med Surg Small Anim; 1997 Aug; 12(3):206-11. PubMed ID: 9283246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antigen measurement and potency tests: challenges encountered during method development...and lessons learned.
    Kubiak V
    Dev Biol (Basel); 2012; 134():83-91. PubMed ID: 22888599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacillus atrophaeus inactivated spores as a potential adjuvant for veterinary rabies vaccine.
    Oliveira-Nascimento L; Caricati AT; Abdulack-Lopes F; Neves LC; Caricati CP; Penna TC; Stephano MA
    Vaccine; 2012 May; 30(23):3351-4. PubMed ID: 22449426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What are the limits of adjuvanticity?
    Del Giudice G; Podda A; Rappuoli R
    Vaccine; 2001 Oct; 20 Suppl 1():S38-41. PubMed ID: 11587808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral vaccination of fish: Lessons from humans and veterinary species.
    Embregts CW; Forlenza M
    Dev Comp Immunol; 2016 Nov; 64():118-37. PubMed ID: 27018298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators.
    Chauhan N; Tiwari S; Iype T; Jain U
    Expert Rev Vaccines; 2017 May; 16(5):491-502. PubMed ID: 28285554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant Systems for vaccines: 13 years of post-licensure experience in diverse populations have progressed the way adjuvanted vaccine safety is investigated and understood.
    Laupèze B; Hervé C; Di Pasquale A; Tavares Da Silva F
    Vaccine; 2019 Sep; 37(38):5670-5680. PubMed ID: 31420171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine adjuvant properties of probiotic bacteria.
    Licciardi PV; Tang ML
    Discov Med; 2011 Dec; 12(67):525-33. PubMed ID: 22204769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal vaccines: Strategies and challenges.
    Li M; Wang Y; Sun Y; Cui H; Zhu SJ; Qiu HJ
    Immunol Lett; 2020 Jan; 217():116-125. PubMed ID: 31669546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 12th Annual Conference on Vaccine Research.
    O'Brien J
    Expert Rev Vaccines; 2009 Sep; 8(9):1139-42. PubMed ID: 19722886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvants for veterinary vaccines--types and modes of action.
    Gerdts V
    Berl Munch Tierarztl Wochenschr; 2015; 128(11-12):456-63. PubMed ID: 26697712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intradermal powder immunization with protein-containing vaccines.
    Weissmueller NT; Schiffter HA; Pollard AJ
    Expert Rev Vaccines; 2013 Jun; 12(6):687-702. PubMed ID: 23750797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oil-based emulsion vaccine adjuvants.
    Schijns VEJC; Strioga M; Ascarateil S
    Curr Protoc Immunol; 2014 Aug; 106():2.18.1-2.18.7. PubMed ID: 25081910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Adjuvants and Immunomodulators for Veterinary Vaccines.
    Heegaard PM; Fang Y; Jungersen G
    Methods Mol Biol; 2016; 1349():63-82. PubMed ID: 26458830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanocarriers for systemic and mucosal vaccine delivery.
    Shahiwala A; Vyas TK; Amiji MM
    Recent Pat Drug Deliv Formul; 2007; 1(1):1-9. PubMed ID: 19075870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.